Clinical Trials Directory

Trials / Completed

CompletedNCT00943683

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing Montelukast With Placebo in Pediatric Patients Aged 6 to 24 Months With Asthma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
256 (actual)
Sponsor
Organon and Co · Industry
Sex
All
Age
6 Months – 24 Months
Healthy volunteers
Not accepted

Summary

A study of Montelukast compared to placebo in asthmatic children aged 6-24 months.

Conditions

Interventions

TypeNameDescription
DRUGmontelukast sodiumMontelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks
DRUGComparator: PlaceboPlacebo oral granules mixed with applesauce once daily at bedtime for 6 weeks

Timeline

Start date
2000-08-01
Primary completion
2001-02-01
Completion
2001-02-01
First posted
2009-07-22
Last updated
2022-02-03
Results posted
2010-06-17

Source: ClinicalTrials.gov record NCT00943683. Inclusion in this directory is not an endorsement.